Key Takeaways
- The FDA budget would remain at the FY 2024 level under a Republican spending bill to fund the government for the remainder of FY 2025, marking two straight years with no taxpayer funding boost.
- The continuing resolution also does not address other policies that were dropped from Congress' 2024 year-end spending bill.
- Democrats oppose the CR because it transfers too much power to the Trump Administration, meaning a government shutdown is possible.
The US Food and Drug Administration would see its second straight year without a boost in taxpayer funds under a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?